Role of chemotherapy in patients with nasopharynx carcinoma treated with radiotherapy (MAC-NPC): an updated individual patient data network meta-analysis.
Petit C, Lee A, Ma J, Lacas B, Ng WT, Chan ATC, Hong RL, Chen MY, Chen L, Li WF, Huang PY, Tan T, Ngan RKC, Zhu G, Mai HQ, Hui EP, Fountzilas G, Zhang L, Carmel A, Kwong DLW, Moon J, Bourhis J, Auperin A, Pignon JP, Blanchard P; MAC-NPC Collaborative Group.
Lancet Oncol. 2023 Jun;24(6):611-623. doi: 10.1016/S1470-2045(23)00163-8.
Childhood Vascular Tumors Treatment (PDQ): Health Professional Version.
PDQ Pediatric Treatment Editorial Board.
2025 Apr 17. In: PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute (US); 2002–.
Childhood Vascular Tumors (PDQ): Patient Version.
PDQ Pediatric Treatment Editorial Board.
2025 Mar 6. In: PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute (US); 2002–.
Prognostic value of serum uric acid and tumor response to induction chemotherapy in locally advanced nasopharyngeal carcinoma.
Xu Y, Wu Z, Ye W, Xiao Y, Zheng W, Chen Q, Bai P, Lin Z, Chen C.
BMC Cancer. 2021 May 8;21(1):519. doi: 10.1186/s12885-021-08285-7.
[A case report of nasopharyngeal inflammatory myofibroblastoma in infant].
Cheng C, Zhong J, Wang S, Liu D.
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2023 Dec;37(12):989-992. doi: 10.13201/j.issn.2096-7993.2023.12.013.
The effect of skeletal muscle mass on dose-limiting toxicities during (chemo)radiotherapy in patients with head and neck cancer: A systematic review and meta-analysis.
Schaeffers AWMA, Scholten HA, van Beers MA, Meussen BW, Smid EJ, van Gils CH, Devriese LA, de Bree R.
Oral Oncol. 2024 Oct;157:106978. doi: 10.1016/j.oraloncology.2024.106978. Epub 2024 Aug 6.
Paraneoplastic Scleroderma: Are There Any Clues?
Jedlickova H, Durčanská V, Vašků V.
Acta Dermatovenerol Croat. 2016 Apr;24(1):78-80.
Fibroblastic-myofibroblastic tumors in children and adolescents: a clinicopathologic study of 108 examples in 103 patients.
Coffin CM, Dehner LP.
Pediatr Pathol. 1991 Jul-Aug;11(4):569-88. doi: 10.3109/15513819109064791.
Can Radiation Therapy Quality Assurance Improve Nasopharyngeal Cancer Outcomes in Low- and Middle-Income Countries: Reporting the First Phase of a Prospective International Atomic Energy Agency Study.
Corry J, Ng WT, Moore A, Choi HCW, Le Q, Holmes S, Munandar A, Wang S, Camacho A, Setakornnukul J, Jiarpinitnun C, Hiep PN, Laskar SG, Benjaafar N, Faheem M, Jin F, Ammar CNB, Ali R, Boualga K, Abdelwahab S, Sommat K, Tao Y, O'Sullivan B, Lee N, Zubizaretta E, Prajogi B, Hopkins K, Rosenblatt E, Lee AWM.
Int J Radiat Oncol Biol Phys. 2021 Dec 1;111(5):1227-1236. doi: 10.1016/j.ijrobp.2021.08.013. Epub 2021 Aug 19.
CD3+T-lymphocyte infiltration is an independent prognostic factor for advanced nasopharyngeal carcinoma.
Al-Rajhi N, Soudy H, Ahmed SA, Elhassan T, Mohammed SF, Khoja HA, Ghebeh H.
BMC Cancer. 2020 Mar 21;20(1):240. doi: 10.1186/s12885-020-06757-w.
